PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FPHAX vs. SHGTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Performance

FPHAX vs. SHGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Columbia Seligman Global Technology Fund (SHGTX). The values are adjusted to include any dividend payments, if applicable.

400.00%450.00%500.00%550.00%600.00%JuneJulyAugustSeptemberOctoberNovember
481.71%
482.09%
FPHAX
SHGTX

Returns By Period

In the year-to-date period, FPHAX achieves a 10.38% return, which is significantly lower than SHGTX's 20.89% return. Over the past 10 years, FPHAX has underperformed SHGTX with an annualized return of 3.06%, while SHGTX has yielded a comparatively higher 9.92% annualized return.


FPHAX

YTD

10.38%

1M

-12.39%

6M

-7.31%

1Y

15.38%

5Y (annualized)

4.10%

10Y (annualized)

3.06%

SHGTX

YTD

20.89%

1M

1.66%

6M

8.98%

1Y

24.01%

5Y (annualized)

10.89%

10Y (annualized)

9.92%

Key characteristics


FPHAXSHGTX
Sharpe Ratio1.051.14
Sortino Ratio1.531.60
Omega Ratio1.191.21
Calmar Ratio0.951.07
Martin Ratio3.995.78
Ulcer Index4.20%4.11%
Daily Std Dev15.93%20.78%
Max Drawdown-37.34%-82.03%
Current Drawdown-17.64%-2.50%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FPHAX vs. SHGTX - Expense Ratio Comparison

FPHAX has a 0.75% expense ratio, which is lower than SHGTX's 1.29% expense ratio.


SHGTX
Columbia Seligman Global Technology Fund
Expense ratio chart for SHGTX: current value at 1.29% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.29%
Expense ratio chart for FPHAX: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%

Correlation

-0.50.00.51.00.6

The correlation between FPHAX and SHGTX is 0.59, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Risk-Adjusted Performance

FPHAX vs. SHGTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Columbia Seligman Global Technology Fund (SHGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FPHAX, currently valued at 1.05, compared to the broader market0.002.004.001.051.14
The chart of Sortino ratio for FPHAX, currently valued at 1.53, compared to the broader market0.005.0010.001.531.60
The chart of Omega ratio for FPHAX, currently valued at 1.19, compared to the broader market1.002.003.004.001.191.21
The chart of Calmar ratio for FPHAX, currently valued at 0.95, compared to the broader market0.005.0010.0015.0020.0025.000.951.07
The chart of Martin ratio for FPHAX, currently valued at 3.99, compared to the broader market0.0020.0040.0060.0080.00100.003.995.78
FPHAX
SHGTX

The current FPHAX Sharpe Ratio is 1.05, which is comparable to the SHGTX Sharpe Ratio of 1.14. The chart below compares the historical Sharpe Ratios of FPHAX and SHGTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
1.05
1.14
FPHAX
SHGTX

Dividends

FPHAX vs. SHGTX - Dividend Comparison

FPHAX's dividend yield for the trailing twelve months is around 0.77%, while SHGTX has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
FPHAX
Fidelity Select Pharmaceuticals Portfolio
0.77%0.63%1.33%1.17%1.31%1.31%1.44%1.33%1.07%5.59%5.81%11.12%
SHGTX
Columbia Seligman Global Technology Fund
0.00%0.00%0.00%0.00%0.27%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

FPHAX vs. SHGTX - Drawdown Comparison

The maximum FPHAX drawdown since its inception was -37.34%, smaller than the maximum SHGTX drawdown of -82.03%. Use the drawdown chart below to compare losses from any high point for FPHAX and SHGTX. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-17.64%
-2.50%
FPHAX
SHGTX

Volatility

FPHAX vs. SHGTX - Volatility Comparison

Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 5.80% compared to Columbia Seligman Global Technology Fund (SHGTX) at 5.30%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than SHGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%JuneJulyAugustSeptemberOctoberNovember
5.80%
5.30%
FPHAX
SHGTX